About us

At 48Hour Discovery, we believe that molecular discovery should not be the rate-limiting step for developing drug therapeutics and diagnostics. Our mission is to offer ligand screening services at a revolutionary price, with unprecedented turnaround time, while leading the way for our clients to access ligand ownership.

Founded in Alberta in 2017, 48Hour Discovery is a biotechnology company committed to building new technologies that make ligand discovery fastereasier, and transparent. We believe that molecular discovery should not be the rate-limiting step for developing therapeutics or diagnostics. Our mission is to provide ligand screening services at a revolutionary price, with unprecedented turnaround time, while leading the way for our clients to access ligand ownership. In 48Hour discovery, we bring our research to the next level to help enable new discoveries for the pharmaceutical and biotech industries and to empower research in the academia.

Learn more about our team >

Our Approach

Optimized Molecular Libraries
to explore diverse chemical space

Learn more >

Streamlined Discovery Platform
to cut-down waiting time for results turnover

Learn more >

Powerful Analysis Suite
to transform results into descriptive visual analytics

Learn more >

Join Us for an Inside Look of our Technology
Join us for an exclusive tour of our molecular discovery platform. This half day workshop will take you through our exciting new technology and will involve hands-on experiments and real-time data analysis….
Continue Reading →

48Hour Discovery Enters into Agreement with TumorGenesis
Edmonton – 48Hour Discovery Inc. announced today that they have signed an agreement with Precision Therapeutics Inc. and its wholly owned subsidiary, TumerGenesis Inc. 48HD will grant access to its patented molecular discovery technology, enabling TumorGenesis to develop precision cancer therapy models…
Continue Reading →

Technical Updates

Coming soon!